 | Up a level |
Pollard, Richard B., Rockstroh, Jurgen K., Pantaleo, Giuseppe, Asmuth, David M., Peters, Barry, Lazzarin, Adriano, Garcia, Felipe, Ellefsen, Kim, Podzamczer, Daniel, van Lunzen, Jan, Arasteh, Keikawus, Schuermann, Dirk, Clotet, Bonaventura, Hardy, W. David, Mitsuyasu, Ronald, Moyle, Graeme, Plettenberg, Andreas, Fisher, Martin, Fatkenheuer, Gerd, Fischl, Margaret, Taiwo, Babafemi, Baksaas, Ingebjorg, Jolliffe, Darren, Persson, Stefan, Jelmert, Oyvind, Hovden, Arnt-Ove, Sommerfelt, Maja A., Wendel-Hansen, Vidar and Sorensen, Birger (2014). Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis., 14 (4). S. 291 - 301. OXFORD: ELSEVIER SCI LTD. ISSN 1474-4457
Rockstroh, Juergen K., Plonski, Frank, Bansal, Meena, Faetkenheuer, Gerd, Small, Catherine B., Asmuth, David M., Pialoux, Gilles, Zhang-Roper, Rebecca, Wang, Ronnie, Pineda, Juan A. 
ORCID: 0000-0002-3751-0296 and Heera, Jayvant
(2017).
Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial.
Antivir. Ther., 22 (3).
S. 263 - 270.
LONDON:
INT MEDICAL PRESS LTD.
ISSN 1359-6535
Rockstroh, Juergen K., Soriano, Vicente ORCID: 0000-0002-4624-5199, Plonski, Frank, Bansal, Meena, Faetkenheuer, Gerd, Small, Catherine B., Asmuth, David M., Pialoux, Gilles, Mukwaya, Geoffrey, Jagannatha, Shyla, Heera, Jayvant and Pineda, Juan A. ORCID: 0000-0002-3751-0296
(2015).
Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents.
HIV Clin. Trials, 16 (2).
S. 72 - 81.
LEEDS:
MANEY PUBLISHING.
ISSN 1945-5771
Rockstroh, Juergen K., Soriano, Vicente ORCID: 0000-0002-4624-5199, Plonski, Frank, Bansal, Meena, Faetkenheuer, Gerd, Small, Catherine B., Asmuth, David M., Pialoux, Gilles, Mukwaya, Geoffrey, Jagannatha, Shyla, Heera, Jayvant and Pineda, Juan A. ORCID: 0000-0002-3751-0296
(2015).
Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents.
HIV Clin. Trials, 16 (2).
S. 72 - 81.
LEEDS:
MANEY PUBLISHING.
ISSN 1945-5771